Mark Jeffery

3.5k total citations · 1 hit paper
77 papers, 2.1k citations indexed

About

Mark Jeffery is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Management Information Systems. According to data from OpenAlex, Mark Jeffery has authored 77 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Management Information Systems. Recurrent topics in Mark Jeffery's work include Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (9 papers) and Genetic and phenotypic traits in livestock (7 papers). Mark Jeffery is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (9 papers) and Genetic and phenotypic traits in livestock (7 papers). Mark Jeffery collaborates with scholars based in New Zealand, Australia and United States. Mark Jeffery's co-authors include Brigid E Hickey, Phil Hider, Vinod Ganju, Donald Richards, Charles S. Fuchs, Rafal Wierzbicki, Adrienne M See, Edith P. Mitchell, Raoudha Soufi‐Mahjoubi and José Barrueco and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Mark Jeffery

64 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study

2007 665 citations Charles S. Fuchs, John L. Marshall et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Jeffery New Zealand	19	1.2k	492	339	259	257	77	2.1k
Jung Young Lee South Korea	28	943 0.8×	553 1.1×	216 0.6×	350 1.4×	496 1.9×	92	2.6k
Giuseppe Catalano Italy	27	1.1k 0.9×	842 1.7×	49 0.1×	359 1.4×	295 1.1×	108	2.6k
Jean‐Noël Talbot France	38	1.0k 0.9×	1.7k 3.4×	288 0.8×	970 3.7×	474 1.8×	232	5.5k
Hans Pruijt Netherlands	26	864 0.7×	361 0.7×	46 0.1×	350 1.4×	246 1.0×	76	2.3k
John P. Curtin United States	39	1.1k 0.9×	556 1.1×	59 0.2×	1.8k 6.9×	229 0.9×	185	5.4k
Huamao Wang China	18	876 0.8×	122 0.2×	155 0.5×	57 0.2×	139 0.5×	51	1.6k
Gernot Kaiser Germany	20	254 0.2×	231 0.5×	446 1.3×	510 2.0×	70 0.3×	67	1.4k
Helén Anderson Australia	22	476 0.4×	340 0.7×	45 0.1×	490 1.9×	171 0.7×	101	2.3k
Judith McKay United Kingdom	23	1.1k 1.0×	309 0.6×	38 0.1×	204 0.8×	599 2.3×	50	2.4k
Ho‐Min Chen Taiwan	21	320 0.3×	195 0.4×	49 0.1×	154 0.6×	144 0.6×	97	1.5k

Countries citing papers authored by Mark Jeffery

Since Specialization

Citations

This map shows the geographic impact of Mark Jeffery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jeffery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jeffery more than expected).

Fields of papers citing papers by Mark Jeffery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Jeffery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jeffery. The network helps show where Mark Jeffery may publish in the future.

Co-authorship network of co-authors of Mark Jeffery

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Jeffery. A scholar is included among the top collaborators of Mark Jeffery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Jeffery. Mark Jeffery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Di, Hao‐Wen Sim, Lillian L. Siu, et al.. (2023). Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer. Clinical Colorectal Cancer. 22(4). 457–463.

Subramaniam, Shalini, Guy C. Toner, Martin R. Stockler, et al.. (2021). P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumors (GCTs).. Journal of Clinical Oncology. 39(6_suppl). TPS390–TPS390. 1 indexed citations

Pérez, David, Katrina Sharples, Reuben Broom, et al.. (2015). A randomised phase IIb trial to assess the efficacy of ReCharge ice cream in preventing chemotherapy-induced diarrhoea. Supportive Care in Cancer. 23(11). 3307–3315. 8 indexed citations

Gracián, Antonio Cubillo, Michael B. Jameson, Enrique Grande, et al.. (2014). A phase 1b study of the anticancer stem cell agent demcizumab (DEM) and gemcitabine (GEM) with or without paclitaxel protein bound particles (nab-paclitaxel) in patients with pancreatic cancer.. Journal of Clinical Oncology. 32(3_suppl). 279–279. 7 indexed citations

Cubillo, Antonio, Michael B. Jameson, Enrique Grande, et al.. (2013). Abstract B78: A Phase Ib study of demcizumab (DEM, anti-DLL4) with gemcitabine (GEM) in patients with first line locally advanced or metastatic pancreatic cancer.. Molecular Cancer Therapeutics. 12(11_Supplement). B78–B78. 1 indexed citations

Parnaby, C. N., William C. Bailey, Lutz Beckert, et al.. (2011). Pulmonary staging in colorectal cancer: a review. Colorectal Disease. 14(6). 660–670. 62 indexed citations

Powell, Erin, Christos S. Karapetis, Derek J. Jonker, et al.. (2010). Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)—results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care. Annals of Oncology. 22(1). 118–126. 33 indexed citations

James, Melissa, Margot Lehman, Phil Hider, et al.. (2010). Fraction size in radiation treatment for breast conservation in early breast cancer. Cochrane Database of Systematic Reviews. CD003860–CD003860. 36 indexed citations

James, Melissa, Margot Lehman, Phil Hider, et al.. (2008). Fraction size in radiation treatment for breast conservation in early breast cancer. Cochrane Database of Systematic Reviews. 7(3). CD003860–CD003860. 84 indexed citations

10.

Fuchs, Charles S., John L. Marshall, E. Mitchell, et al.. (2007). Updated results of BICC-C study comparing first-line irinotecan/fluoropymidine combinations with or without celecoxib in mCRC: Updated efficacy data. Journal of Clinical Oncology. 25(18_suppl). 4027–4027. 22 indexed citations

11.

Benaroch, Michel, et al.. (2007). Option-Based Risk Management: A Field Study of Sequential Information Technology Investment Decisions. Journal of Management Information Systems. 24(2). 103–140. 73 indexed citations

12.

Jeffery, Mark, et al.. (2004). Best Practices in IT Portfolio Management. MIT Sloan management review. 45(3). 41–49. 198 indexed citations

13.

Jeffery, Mark, et al.. (2004). Information Technology and Workers' Privacy: Notice and Consent. SSRN Electronic Journal. 1 indexed citations

14.

Jeffery, Mark, et al.. (2003). REAL OPTIONS AND ENTERPRISE TECHNOLOGY PROJECT SELECTION AND DEPLOYMENT STRATEGIES. 7 indexed citations

15.

Jeffery, Mark. (2002). Information Technology and Workers' Privacy: The English Law. SSRN Electronic Journal. 23(2). 301. 3 indexed citations

16.

Jeffery, Mark, et al.. (2002). Information Technology and Workers' Privacy: Notice and Consent. Comparative labor law & policy journal. 23(2). 551. 3 indexed citations

17.

Jeffery, Mark. (2002). Information Technology and Workers' Privacy: Introduction. SSRN Electronic Journal. 23(2). 251. 2 indexed citations

18.

Jeffery, Mark. (2001). Association of Cancer Online Resources. The Lancet Oncology. 2(6). 391–391. 7 indexed citations

19.

Gazzola, Carlo, et al.. (2000). Scrotal circumference at puberty and its relationship to testes mass in three genotypes of beef cattle. Queensland Department of Agriculture and Fisheries archive of scientific and research publications (Queensland Department of Agriculture and Fisheries).

20.

Loxton, I., et al.. (1992). Protein supplementation and growth enhancer strategies in successive years to maximise growth of Brahman cross steers grazing sown grass pastures on brigalow lands. Queensland Department of Agriculture and Fisheries archive of scientific and research publications (Queensland Department of Agriculture and Fisheries). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact